Reply
- PMID: 38351441
- DOI: 10.1002/art.42823
Reply
References
-
- Trinh‐Minh T, Györfi AH, Tomcik M, et al. Anti‐S100A4 monoclonal antibody treatment ameliorates experimental skin fibrosis and SSc‐specific transcriptional signatures in human skin. Arthritis Rheumatol Published online December 18, 2023. doi:https://doi.org/10.1002/art.42781
-
- Dees C, Tomcik M, Palumbo‐Zerr K, et al. JAK‐2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis. Arthritis Rheum 2012;64(9):3006–3015.
-
- Zhang Y, Dees C, Beyer C, et al. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis. Ann Rheum Dis 2015;74(5):936–943.
-
- Zhang Y, Liang R, Chen CW, et al. JAK1‐dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long‐term treatment. Ann Rheum Dis 2017;76(8):1467–1475.
-
- Pedroza M, To S, Assassi S, et al. Role of STAT3 in skin fibrosis and transforming growth factor beta signalling. Rheumatology (Oxford) 2018;57(10):1838–1850.
Publication types
LinkOut - more resources
Full Text Sources